Literature DB >> 28515499

Comment on Tapentadol and Serotonin Syndrome.

Michael E Mullins, William H Dribben.   

Abstract

Entities:  

Year:  2017        PMID： 28515499      PMCID： PMC5424824          DOI： 10.1310/hpj5204-246

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  6 in total

1.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

Review 2.  Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology.

Authors:  D Seger; K Barker; C McNaughton
Journal:  Clin Toxicol (Phila)       Date:  2013-06-18       Impact factor: 4.467

3.  ISMP Adverse Drug Reactions.

Authors: 
Journal:  Hosp Pharm       Date:  2013-07

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Probable Tapentadol-Associated Serotonin Syndrome After Overdose.

Authors:  Heather Walczyk; Cheuk H Michael Liu; Antonia Alafris; Henry Cohen
Journal:  Hosp Pharm       Date:  2016-04

6.  Case report of a fatal intoxication by Nucynta.

Authors:  Dori M Franco; Zabiullah Ali; Barry Levine; Robert A Middleberg; David R Fowler
Journal:  Am J Forensic Med Pathol       Date:  2014-12       Impact factor: 0.921
  6 in total
  1 in total

Review 1.  Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic.

Authors:  Ariane Stollenwerk; Melanie Sohns; Fabian Heisig; Christian Elling; Detlef von Zabern
Journal:  Adv Ther       Date:  2017-12-21       Impact factor: 3.845
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.